Bold Debates on the Future of Thrombectomy in Stroke: ESOC 2025
European Stroke Organisation (ESO) shared an insightful post on X:
”Couldn’t attend live? Explore one of the key discussions from Day 2 at ESOC 2025 in Helsinki. Our guests debate large core trial results: Are questions still open? Should thrombectomy be for all?”
Watch the key discussions here.
At ESOC 2025 in Helsinki, one of the key discussions on Day 2 centered on the evolving evidence from large core stroke trials.
Experts Anne Hege Nymoen Aamodt and Götz Thomalla debated whether current results fully address the complexities of patient selection and whether thrombectomy should be expanded to all patients.
The session highlighted ongoing uncertainties and the need for further research to refine treatment strategies in this challenging stroke population.
Do not miss the latest updates on global discussions, stay tuned with Hemostasis Today.
-
Aug 22, 2026, 13:21Chokri Ben Lamine: ASH 2026 Adult Primary ITP Guidelines – Practice-Changing Update
-
Aug 22, 2026, 13:07Saneha Anjum Shaikh: Blood Bank Basics and Quality Control in Automation
-
Aug 22, 2026, 11:36Bernardo Gindri: How platelets Influence Cancer Progression
-
Aug 22, 2026, 11:34Nick Gehrig: Extending Platelet Shelf Life to Strengthen Blood Supply
-
Aug 22, 2026, 11:14Lei Yu: New Guidance for Acute Pulmonary Embolism in 2026
-
Aug 22, 2026, 11:01Neeraj Songara: Shelf-Stable Synthetic Blood – The Future of Emergency Transfusion?
-
Aug 22, 2026, 10:41Mike R.։ VTE Thrombectomy – Defining What Success Really Means
-
Aug 22, 2026, 10:28Steven Meier: What Happens During PRP Therapy?
-
Aug 22, 2026, 10:05Ralf Ludwig: When a Promising Biomarker Falls Short